top read note buysid
import report highlight
top read note list rank order key report jefbio team re-highlight
top team note includ list upcom catalyst biopharma
preview planner highlight import dataset watch recent develop w/
on-going amrn litig red carpet note highlight upcom event rest top
report insid full tabl addit highlight add analyst report
contain uniqu insight differenti view revisit
top note may top insid tabl
industri what biopharma upcom catalyst focu may
industri asco top dataset watch planner insid may
amrn new litig develop settlement possibl apr
industri red carpet lot upcom biotech event may
spoke management roxa event rate lower may
industri chart week biotech ipo may
highli anticip top-line updat interim data valrox
gene therapi hemophilia share view updat
exce physician expect recent poll median/mean fviii
activ normal vs year importantli interim data
achiev pre-specifi fviii level acceler approv meet fda
up pt vs prior increas probabl success
valrox arri interim beacon studi braftovi/mektovi/erbitux
brafm colorect cancer success hit overal surviv endpoint posit
surpris forecast total peak revenu braftovi/mektovi arri
believ arri one attract oncolog asset biotech up pt
vs prior increas probabl beacon regulatori success
data updat reveal abstract suggest til therapi
could open door cell therapi lucr solid-tumor market compani report
new patient progress melanoma trial offer first evid
clinic meaning durabl til therapi also cervic data report orr
greater report w/ keytruda similar patient popul share
move next day predict note
literatur research reveal potenti culprit resist bcma therapi one
consist theme across bcma pi/ii clinic dataset lack
durabl remiss highlight two recent scientif public solubl bcma
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
could hinder activ bcma-target therapi one paper report data
pt treat upenn car-t lack respons lack durabl remiss
correl solubl bcma level
pleas see import disclosur inform page report
follow esrx decis exclud ingrezza analyz manag care
formulari use public avail payer databas gain better perspect
coverag although commerci live expos formulari austedo
prefer exclus ingrezza report call teva note
access advantag austedo expect rebat war bode well
ingrezza growth prospect roadmap gallop readout
gpp set expect ahead data expect cross-trial analysi
off-label biolog arriv mjda reduct point align manag
guidanc reduct put efficaci par off-label option think
outcom set registr studi gpp could lift share vs
declin weaker data
held kol call provid perspect
space follow bcrx top-lin ph iii data led model
updat addl thought upcom focus mrtx/amgn
srra zlab sbph tcon abstract note eha
focus srra abstract note also attend asgct
sever compani updat includ
note two pivot readout friedreich ataxia
alport expect highlight updat baselin characterist
also note discuss adpkd co recent
present highli read along w/ note summar investor event
verg potenti breakthrough microbiome-bas therapeut
meaning clinic readout next month launch coverag
three lead compani space along initi
report comprehens white paper cover key aspects/deb bring
new drug class real world use white paper drill
microbiome-bas therapeut work key debates/sensit
space includ ip manufactur regulatori treatment buy pt
top-pick among three compani like name
differenti broad platform support robust scienc current program could
buy pt also posit name elegantli turn probiot
pharmaceut machineri rare metabol disord potenti immuno-oncolog
estim combin risk-adjust peak sale hold pt
sidelin strong convict clinical/commerci
success lead program due addit work need cmc/suppli lack clear
mechanist understand
pleas see import disclosur inform page report
pleas see import disclosur inform page report
tickertitled biopharma upcom catalyst focu onmay top dataset watch planner insidemay litig develop settlement possibl red carpet lot upcom event jefferiesmay spoke management roxa event rate lower stock reboundmay hit non-inferior market debatesmay week ipo may deep dive slide base biz durabl worth call docmay gene therapi still look good survey suggest keen uptak time may kra data show respons earli timepoint let game begin may followup could orr lung may hiv call watch gsk doublet long-act competitor may day amrn may call takeaway day list prioriti may littl rough edg upcom event drive stockmay vs consensu underst inventori drawdown etcmay roxa studi start broaden market astella confid mace data may new begin look build pipelin time buymay kra discuss debat first datamay day depress session axsmmay day begin good/solid notabl standout us buymay thought ep tomorrow cfo chang may convo management investor discuss catalyst path may quick hit minutesmay ii sma studi underway first interim efficaci data catalystmay gene therapi come label appar unclearmay guidanc raiseddeb nash launch underway buymay nda accept fda say adcom neededmay discuss valrox point like durabl efficaci year read researchmay day summari minut run-downmay expert panel ttr amyloidosismay nda file year track pot card buymay blue margin simpli enough pt day expert view read alny/ions/pf tafamidi approvalmay call seri may hiv conf call deep dive slidesmay microbiom focusmay poll expect valrox data potenti utilizationmay data come juli sentiment setup thought data new off-the-shelf platform come buymay take time w/ reimburs access etc maintain holdmay meet takeaway new depress data come earli expert event nmosd drug developmentmay data immin w/ readthrough oral formul pt final cr rate continu impress w/ encourag durabilitymay nda accept potenti big set-up may clariti timelin bla re-submiss earli buymay expect meet share de-risk reiter buymay in-lin like debat go data though stock cheapmay beacon success interim strong overal surviv benefitsmay equiti research
inform compani recommend
report pleas visit websit http //
javatar bluematrix com/sellside/disclosur action call
michael yee certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
biren amin certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
eun yang ph certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
mauri raycroft ph certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli indirectli
relat specif recommend view express research report
chri howerton phd certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli indirectli
relat specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
jefferi llc act financi advisor kite pharma kite sale compani
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr amarin corpor
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr array biopharma inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr precis bioscienc inc
jefferi group llc make market secur adr fibrogen inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr iovanc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr
jefferi group llc make market secur adr
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr inc
pleas see import disclosur inform page report
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr spring bank pharmaceut inc
jefferi group llc make market secur adr
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr sierra oncolog
jefferi group llc make market secur adr synlog inc
jefferi group llc make market secur adr inc
jefferi group llc make market secur adr zai lab limit
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
abeona inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
amarin corpor within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic amarin corpor
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
amarin corpor one affili
within past twelv month amarin corpor client jefferi llc invest bank servic
provid
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic array biopharma inc
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
precis bioscienc inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic precis bioscienc inc
within past twelv month precis bioscienc inc client jefferi llc invest bank servic
provid
pleas see import disclosur inform page report
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
precis bioscienc inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic iovanc
within past twelv month client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
within past twelv month jefferi llc and/or affili receiv compens product servic
invest bank servic non-invest bank secur relat compens client servic provid neurocrin
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic spring bank pharmaceut inc
within past twelv month spring bank pharmaceut inc client jefferi llc invest bank servic
provid
jefferi group llc affili subsidiari act manag co-manag underwrit placement secur
spring bank pharmaceut inc one affili within past twelv month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic swedish orphan biovitrum ab
within past twelv month swedish orphan biovitrum ab client jefferi llc invest bank servic
provid
jefferi intern ltd affili subsidiari within past month agreement provid invest
servic swedish orphan biovitrum ab
jefferi group llc affili subsidiari expect receiv intend seek compens invest bank servic
inc within next three month
within past month jefferi group llc affili subsidiari receiv compens invest bank
servic inc
within past twelv month inc client jefferi llc invest bank servic
provid
pleas see import disclosur inform page report
